No abstract available
MeSH terms
-
Adverse Drug Reaction Reporting Systems
-
Anti-Inflammatory Agents, Non-Steroidal / adverse effects
-
Cardiovascular Diseases / chemically induced*
-
Celecoxib
-
Cyclooxygenase 2
-
Cyclooxygenase 2 Inhibitors
-
Cyclooxygenase Inhibitors / adverse effects*
-
Cyclooxygenase Inhibitors / therapeutic use
-
Drug Approval
-
Gastrointestinal Hemorrhage / chemically induced
-
Gastrointestinal Hemorrhage / prevention & control
-
Humans
-
Isoxazoles / adverse effects
-
Lactones / adverse effects*
-
Lactones / therapeutic use
-
Membrane Proteins
-
Prostaglandin-Endoperoxide Synthases
-
Pyrazoles / adverse effects*
-
Pyrazoles / therapeutic use
-
Sulfonamides / adverse effects*
-
Sulfonamides / therapeutic use
-
Sulfones / adverse effects*
-
Sulfones / therapeutic use
Substances
-
Anti-Inflammatory Agents, Non-Steroidal
-
Cyclooxygenase 2 Inhibitors
-
Cyclooxygenase Inhibitors
-
Isoxazoles
-
Lactones
-
Membrane Proteins
-
Pyrazoles
-
Sulfonamides
-
Sulfones
-
rofecoxib
-
valdecoxib
-
parecoxib
-
Cyclooxygenase 2
-
PTGS2 protein, human
-
Prostaglandin-Endoperoxide Synthases
-
Celecoxib